Absolute Bioavailability Study With Ipragliflozin

Clinical trial NCT01611428 · COMPLETED

Trial details

NCT number: NCT01611428
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability of Ipragliflozin Healthy Subjects

Start date: 2011-06-01
Primary completion: 2011-07-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.